Keywords
Last Name
Institution

Barbara Murphy

TitleDEAN FOR CLINICAL INTEGRATION AND POPULATION HEALTH
InstitutionMount Sinai
Address5 East 98th Street
12th Floor
New York NY 10029
Phone212-659-8086
    Other Positions
    TitlePROFESSOR & CHAIR
    InstitutionMount Sinai
    DepartmentNephrology


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Bahirwani R, Barin B, Olthoff K, Stock P, Murphy B, Rajender Reddy K. Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the national institutes of health multi-site study. Liver Transpl. 2013 Jun; 19(6):619-26.
      View in: PubMed
    2. Menon MC, Murphy B. Maintenance immunosuppression in renal transplantation. Curr Opin Pharmacol. 2013 Aug; 13(4):662-71.
      View in: PubMed
    3. Allam SR, Krüger B, Mehrotra A, Schiano T, Schröppel B, Murphy B. The association of IL28B polymorphism and graft survival in patients with hepatitis C undergoing liver transplantation. PLoS One. 2013; 8(1):e54854.
      View in: PubMed
    4. Nair V, Sawinski D, Akalin E, Friedlander R, Ebcioglu Z, Sehgal V, Dinavahi R, Khaim R, Ames S, Lerner S, Murphy B, Bromberg JS, Heeger PS, Schröppel B. Effect of high-dose intravenous immunoglobulin on anti-HLA antibodies in sensitized kidney transplant candidates. Clin Transplant. 2012 May-Jun; 26(3):E261-8.
      View in: PubMed
    5. Vlacich G, Diaz R, Thorpe SW, Murphy BA, Kirby W, Sinard RJ, Shakhtour B, Shyr Y, Murphy P, Netterville JL, Yarbrough WG, Cmelak AJ. Intensity-modulated radiation therapy with concurrent carboplatin and paclitaxel for locally advanced head and neck cancer: toxicities and efficacy. Oncologist. 2012; 17(5):673-81.
      View in: PubMed
    6. Le Grande MR, Elliott PC, Worcester MU, Murphy BM, Goble AJ, Kugathasan V, Sinha K. Identifying illness perception schemata and their association with depression and quality of life in cardiac patients. Psychol Health Med. 2012; 17(6):709-22.
      View in: PubMed
    7. Hayes DN, Lucas AS, Tanvetyanon T, Krzyzanowska MK, Chung CH, Murphy BA, Gilbert J, Mehra R, Moore DT, Sheikh A, Hoskins J, Hayward MC, Zhao N, O'Connor W, Weck KE, Cohen RB, Cohen EE. Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elements. Clin Cancer Res. 2012 Apr 1; 18(7):2056-65.
      View in: PubMed
    8. Deng J, Ridner SH, Murphy BA, Dietrich MS. Preliminary development of a lymphedema symptom assessment scale for patients with head and neck cancer. Support Care Cancer. 2012 Aug; 20(8):1911-8.
      View in: PubMed
    9. Gilbert J, Murphy B, Dietrich MS, Henry E, Jordan R, Counsell A, Wirth P, Yarbrough WG, Slebos RJ, Chung CH. Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer. Cancer. 2012 Feb 15; 118(4):1007-13.
      View in: PubMed
    10. Gilbert J, Haman KL, Dietrich MS, Blakely RD, Shelton RC, Murphy BA. Depression in patients with head and neck cancer and a functional genetic polymorphism of the serotonin transporter gene. Head Neck. 2012 Mar; 34(3):359-64.
      View in: PubMed
    11. Dinavahi R, George A, Tretin A, Akalin E, Ames S, Bromberg JS, Deboccardo G, Dipaola N, Lerner SM, Mehrotra A, Murphy BT, Nadasdy T, Paz-Artal E, Salomon DR, Schröppel B, Sehgal V, Sachidanandam R, Heeger PS. Antibodies reactive to non-HLA antigens in transplant glomerulopathy. J Am Soc Nephrol. 2011 Jun; 22(6):1168-78.
      View in: PubMed
    12. Stock PG, Barin B, Murphy B, Hanto D, Diego JM, Light J, Davis C, Blumberg E, Simon D, Subramanian A, Millis JM, Lyon GM, Brayman K, Slakey D, Shapiro R, Melancon J, Jacobson JM, Stosor V, Olson JL, Stablein DM, Roland ME. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med. 2010 Nov 18; 363(21):2004-14.
      View in: PubMed
    13. Krüger B, Yin N, Zhang N, Yadav A, Coward W, Lal G, Zang W, S Heeger P, Bromberg JS, Murphy B, Schröppel B. Islet-expressed TLR2 and TLR4 sense injury and mediate early graft failure after transplantation. Eur J Immunol. 2010 Oct; 40(10):2914-24.
      View in: PubMed
    14. Lin M, Yin N, Murphy B, Medof ME, Segerer S, Heeger PS, Schröppel B. Immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin. Diabetes. 2010 Sep; 59(9):2247-52.
      View in: PubMed
    15. Cohen DJ, Murphy B. Drug coverage for transplantation turns into political football: big business trumps patients. Clin J Am Soc Nephrol. 2010 May; 5(5):746-7.
      View in: PubMed
    16. Dhillon N, Walsh L, Krüger B, Ward SC, Godbold JH, Radwan M, Schiano T, Murphy BT, Schröppel B. A single nucleotide polymorphism of Toll-like receptor 4 identifies the risk of developing graft failure after liver transplantation. J Hepatol. 2010 Jul; 53(1):67-72.
      View in: PubMed
    17. Dhillon N, Walsh L, Krüger B, Mehrotra A, Ward SC, Godbold J, Radwan M, Schiano T, Murphy B, Schröppel B. Complement component C3 allotypes and outcomes in liver transplantation. Liver Transpl. 2010 Feb; 16(2):198-203.
      View in: PubMed
    18. Kim JY, Akalin E, Dikman S, Gagliardi R, Schiano T, Bromberg J, Murphy B, de Boccardo G. The variable pathology of kidney disease after liver transplantation. Transplantation. 2010 Jan 27; 89(2):215-21.
      View in: PubMed
    19. Schröppel B, Krüger B, Walsh L, Yeung M, Harris S, Garrison K, Himmelfarb J, Lerner SM, Bromberg JS, Zhang PL, Bonventre JV, Wang Z, Farris AB, Colvin RB, Murphy BT, Vella JP. Tubular expression of KIM-1 does not predict delayed function after transplantation. J Am Soc Nephrol. 2010 Mar; 21(3):536-42.
      View in: PubMed
    20. Tolcher AW, Sarantopoulos J, Patnaik A, Papadopoulos K, Lin CC, Rodon J, Murphy B, Roth B, McCaffery I, Gorski KS, Kaiser B, Zhu M, Deng H, Friberg G, Puzanov I. Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1. J Clin Oncol. 2009 Dec 1; 27(34):5800-7.
      View in: PubMed
    21. Rafiq MA, de Boccardo G, Schröppel B, Bromberg JS, Sehgal V, Dinavahi R, Murphy B, Akalin E. Differential outcomes in 3 types of acute antibody-mediated rejection. Clin Transplant. 2009 Nov-Dec; 23(6):951-7.
      View in: PubMed
    22. Dinavahi RV, Mehrotra A, Murphy BT, Huprikar S. Human immunodeficiency virus and renal transplantation. Kidney Int. 2009 Oct; 76(8):907-10.
      View in: PubMed
    23. Murphy BA, Chen A, Curran WJ, Garden AS, Harari PM, Wong SJ, Ang KK. Longitudinal oncology registry of head and neck carcinoma (LORHAN): initial supportive care findings. Support Care Cancer. 2009 Nov; 17(11):1393-401.
      View in: PubMed
    24. Montague T, Murphy B. Lipid management in chronic kidney disease, hemodialysis, and transplantation. Endocrinol Metab Clin North Am. 2009 Mar; 38(1):223-34.
      View in: PubMed
    25. Krüger B, Krick S, Dhillon N, Lerner SM, Ames S, Bromberg JS, Lin M, Walsh L, Vella J, Fischereder M, Krämer BK, Colvin RB, Heeger PS, Murphy BT, Schröppel B. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A. 2009 Mar 3; 106(9):3390-5.
      View in: PubMed
    26. Dilts D, Ridner SH, Franco A, Murphy B. Patients with cancer and e-mail: implications for clinical communication. Support Care Cancer. 2009 Aug; 17(8):1049-56.
      View in: PubMed
    27. Zang W, Lin M, Kalache S, Zhang N, Krüger B, Waaga-Gasser AM, Grimm M, Hancock W, Heeger P, Schröppel B, Murphy B. Inhibition of the alloimmune response through the generation of regulatory T cells by a MHC class II-derived peptide. J Immunol. 2008 Dec 1; 181(11):7499-506.
      View in: PubMed
    28. Radbill B, Murphy B, LeRoith D. Rationale and strategies for early detection and management of diabetic kidney disease. Mayo Clin Proc. 2008 Dec; 83(12):1373-81.
      View in: PubMed
    29. Sawinski D, Murphy B. End-stage renal disease and kidney transplant in HIV-infected patients. Semin Nephrol. 2008 Nov; 28(6):581-4.
      View in: PubMed
    30. Murphy BM, Elliott PC, Higgins RO, Le Grande MR, Worcester MU, Goble AJ, Tatoulis J. Anxiety and depression after coronary artery bypass graft surgery: most get better, some get worse. Eur J Cardiovasc Prev Rehabil. 2008 Aug; 15(4):434-40.
      View in: PubMed
    31. Brizel DM, Murphy BA, Rosenthal DI, Pandya KJ, Glück S, Brizel HE, Meredith RF, Berger D, Chen MG, Mendenhall W. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma. J Clin Oncol. 2008 May 20; 26(15):2489-96.
      View in: PubMed
    32. Krüger B, Schröppel B, Murphy BT. Genetic polymorphisms and the fate of the transplanted organ. Transplant Rev (Orlando). 2008 Apr; 22(2):131-40.
      View in: PubMed
    33. Chung CH, Mirakhur B, Chan E, Le QT, Berlin J, Morse M, Murphy BA, Satinover SM, Hosen J, Mauro D, Slebos RJ, Zhou Q, Gold D, Hatley T, Hicklin DJ, Platts-Mills TA. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med. 2008 Mar 13; 358(11):1109-17.
      View in: PubMed
    34. Akalin E, Dinavahi R, Friedlander R, Ames S, de Boccardo G, Sehgal V, Schröppel B, Bhaskaran M, Lerner S, Fotino M, Murphy B, Bromberg JS. Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies. Clin J Am Soc Nephrol. 2008 Jul; 3(4):1160-7.
      View in: PubMed
    35. Murphy BM, Elliott PC, Worcester MU, Higgins RO, Le Grande MR, Roberts SB, Goble AJ. Trajectories and predictors of anxiety and depression in women during the 12 months following an acute cardiac event. Br J Health Psychol. 2008 Feb; 13(Pt 1):135-53.
      View in: PubMed
    36. Akalin E, Dinavahi R, Dikman S, de Boccardo G, Friedlander R, Schroppel B, Sehgal V, Bromberg JS, Heeger P, Murphy B. Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining. Clin J Am Soc Nephrol. 2007 Nov; 2(6):1261-7.
      View in: PubMed
    37. Ommen ES, Schröppel B, Kim JY, Gaspard G, Akalin E, de Boccardo G, Sehgal V, Lipkowitz M, Murphy B. Routine use of ambulatory blood pressure monitoring in potential living kidney donors. Clin J Am Soc Nephrol. 2007 Sep; 2(5):1030-6.
      View in: PubMed
    38. Ommen ES, Winston JA, Murphy B. Medical risks in living kidney donors: absence of proof is not proof of absence. Clin J Am Soc Nephrol. 2006 Jul; 1(4):885-95.
      View in: PubMed
    39. Gallon L, Akalin E, Lynch P, Rothberg L, Parker M, Schiano T, Abecassis M, Murphy B. ACE gene D/D genotype as a risk factor for chronic nephrotoxicity from calcineurin inhibitors in liver transplant recipients. Transplantation. 2006 Feb 15; 81(3):463-8.
      View in: PubMed
    40. Murphy BM, Worcester MU, Elliott PC, Le Grande MR, Higgins RO, Goble AJ. Change in women's dietary fat intake following an acute cardiac event: Extent, predictors and comparison with non-cardiac Australian women and older adults. Eur J Cardiovasc Nurs. 2006 Sep; 5(3):206-13.
      View in: PubMed
    41. Zang W, Murphy B. Peptide-mediated immunosuppression. Am J Ther. 2005 Nov-Dec; 12(6):592-9.
      View in: PubMed
    42. Wyatt CM, Murphy B. Kidney transplantation in HIV-infected patients. Semin Dial. 2005 Nov-Dec; 18(6):495-8.
      View in: PubMed
    43. Zang W, Kalache S, Lin M, Schroppel B, Murphy B. MHC Class II-mediated apoptosis by a nonpolymorphic MHC Class II peptide proceeds by activation of protein kinase C. J Am Soc Nephrol. 2005 Dec; 16(12):3661-8.
      View in: PubMed
    44. Herman ES, Rafey MA, Akalin E, Winston JA, Murphy B. Blood pressure and renal function after kidney donation from hypertensive living donors. Transplantation. 2005 Jun 27; 79(12):1768-9; author reply 1769-70.
      View in: PubMed
    45. Wyatt CM, Dikman S, Sehgal V, Murphy BT, Bromberg JS, Ames S, Akalin E. Chronic organizing microangiopathy in a renal transplant recipient. Nephrol Dial Transplant. 2005 Aug; 20(8):1734-7.
      View in: PubMed
    46. Akalin E, Ames S, Sehgal V, Murphy B, Bromberg JS. Safety of using hepatitis B virus core antibody or surface antigen-positive donors in kidney or pancreas transplantation. Clin Transplant. 2005 Jun; 19(3):364-6.
      View in: PubMed
    47. Gibson MK, Li Y, Murphy B, Hussain MH, DeConti RC, Ensley J, Forastiere AA. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2005 May 20; 23(15):3562-7.
      View in: PubMed
    48. Akalin E, Ames S, Sehgal V, Murphy B, Bromberg JS, Fotino M, Friedlander R. Intravenous immunoglobulin and thymoglobulin induction treatment in immunologically high-risk kidney transplant recipients. Transplantation. 2005 Mar 27; 79(6):742.
      View in: PubMed
    49. Akalin E, Sehgal V, Murphy B, Akalin E, Sehgal V, Ames S, Bromberg JS, Murphy B, Dikman S, Fotino M. Intravenous immunoglobulin treatment in a kidney transplant patient with chronic allograft nephropathy. Transplantation. 2005 Jan 27; 79(2):257-8.
      View in: PubMed
    50. Schröppel B, Zhang N, Chen P, Chen D, Bromberg JS, Murphy B. Role of donor-derived monocyte chemoattractant protein-1 in murine islet transplantation. J Am Soc Nephrol. 2005 Feb; 16(2):444-51.
      View in: PubMed
    51. Akalin E, Murphy B, Sehgal V, Ames S, Daly L, Bromberg JS. Rapid steroid withdrawal in hepatitis C virus-positive kidney transplant recipients. Clin Transplant. 2004 Aug; 18(4):384-9.
      View in: PubMed
    52. Worcester MU, Murphy BM, Mee VK, Roberts SB, Goble AJ. Cardiac rehabilitation programmes: predictors of non-attendance and drop-out. Eur J Cardiovasc Prev Rehabil. 2004 Aug; 11(4):328-35.
      View in: PubMed
    53. Schröppel B, Zhang N, Chen P, Zang W, Chen D, Hudkins KL, Kuziel WA, Sung R, Bromberg JS, Murphy B. Differential expression of chemokines and chemokine receptors in murine islet allografts: the role of CCR2 and CCR5 signaling pathways. J Am Soc Nephrol. 2004 Jul; 15(7):1853-61.
      View in: PubMed
    54. El Sayegh S, Keller MJ, Huprikar S, Murphy B. Solid organ transplantation in HIV-infected recipients. Pediatr Transplant. 2004 Jun; 8(3):214-21.
      View in: PubMed
    55. Argiris A, Li Y, Murphy BA, Langer CJ, Forastiere AA. Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy. J Clin Oncol. 2004 Jan 15; 22(2):262-8.
      View in: PubMed
    56. Akalin E, Bromberg JS, Sehgal V, Ames S, Murphy B. Decreased incidence of cytomegalovirus infection in thymoglobulin-treated transplant patients with 6 months of valganciclovir prophylaxis. Am J Transplant. 2004 Jan; 4(1):148-9.
      View in: PubMed
    57. Akalin E, Ames S, Sehgal V, Fotino M, Daly L, Murphy B, Bromberg JS. Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients. Transplantation. 2003 Nov 27; 76(10):1444-7.
      View in: PubMed
    58. Zhang N, Schröppel B, Chen D, Fu S, Hudkins KL, Zhang H, Murphy BM, Sung RS, Bromberg JS. Adenovirus transduction induces expression of multiple chemokines and chemokine receptors in murine beta cells and pancreatic islets. Am J Transplant. 2003 Oct; 3(10):1230-41.
      View in: PubMed
    59. Schröppel B, Murphy B. Gene variants affecting bioavailability of drugs: towards individualized immunosuppressive therapy? J Am Soc Nephrol. 2003 Jul; 14(7):1955-7.
      View in: PubMed
    60. Murphy B, Yu J, Jiao Q, Lin M, Chitnis T, Sayegh MH. A novel mechanism for the immunomodulatory functions of class II MHC-derived peptides. J Am Soc Nephrol. 2003 Apr; 14(4):1053-65.
      View in: PubMed
    61. Marder BA, Schröppel B, Lin M, Schiano T, Parekh R, Tomer Y, Murphy B. The impact of costimulatory molecule gene polymorphisms on clinical outcomes in liver transplantation. Am J Transplant. 2003 Apr; 3(4):424-31.
      View in: PubMed
    62. Marder B, Schröppel B, Murphy B. Genetic variability and transplantation. Curr Opin Urol. 2003 Mar; 13(2):81-9.
      View in: PubMed
    63. Dutcher JP, Fine JP, Krigel RL, Murphy BA, Schaefer PL, Ernstoff MS, Loehrer PJ. Stratification by risk factors predicts survival on the active treatment arm in a randomized phase II study of interferon-gamma plus/minus interferon-alpha in advanced renal cell carcinoma (E6890). Med Oncol. 2003; 20(3):271-81.
      View in: PubMed
    64. Schröppel B, Fischereder M, Lin M, Marder B, Schiano T, Krämer BK, Murphy B. Analysis of gene polymorphisms in the regulatory region of MCP-1, RANTES, and CCR5 in liver transplant recipients. J Clin Immunol. 2002 Nov; 22(6):381-5.
      View in: PubMed
    65. Krüger B, Schröppel B, Ashkan R, Marder B, Zülke C, Murphy B, Krämer BK, Fischereder M. A Monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation. J Am Soc Nephrol. 2002 Oct; 13(10):2585-9.
      View in: PubMed
    66. Schröppel B, Fischereder M, Ashkar R, Lin M, Krämer BK, Mardera B, Schiano T, Murphy B. The impact of polymorphisms in chemokine and chemokine receptors on outcomes in liver transplantation. Am J Transplant. 2002 Aug; 2(7):640-5.
      View in: PubMed
    67. Motzer RJ, Bacik J, Murphy BA, Russo P, Mazumdar M. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol. 2002 Jan 1; 20(1):289-96.
      View in: PubMed
    68. Motzer RJ, Rakhit A, Thompson JA, Nemunaitis J, Murphy BA, Ellerhorst J, Schwartz LH, Berg WJ, Bukowski RM. Randomized multicenter phase II trial of subcutaneous recombinant human interleukin-12 versus interferon-alpha 2a for patients with advanced renal cell carcinoma. J Interferon Cytokine Res. 2001 Apr; 21(4):257-63.
      View in: PubMed
    69. Motzer RJ, Murphy BA, Bacik J, Schwartz LH, Nanus DM, Mariani T, Loehrer P, Wilding G, Fairclough DL, Cella D, Mazumdar M. Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma. J Clin Oncol. 2000 Aug; 18(16):2972-80.
      View in: PubMed
    70. Moasser MM, Motzer RJ, Khoo KS, Lyn P, Murphy BA, Bosl GJ, Dmitrovsky E. all-trans retinoic acid for treating germ cell tumors. In vitro activity and results of a phase II trial. Cancer. 1995 Aug 15; 76(4):680-6.
      View in: PubMed
    Murphy's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067